Wharton Business Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-42,475
| Closed | -$4.11M | – | 101 |
|
|
2017
Q4 | $4.11M | Hold |
42,475
| – | – | 0.43% | 39 |
|
|
2017
Q3 | $3.77M | Sell |
42,475
-390
| -0.9% | -$34.7K | 0.4% | 40 |
|
|
2017
Q2 | $3.11M | Sell |
42,865
-1,195
| -3% | -$86.6K | 0.33% | 46 |
|
|
2017
Q1 | $2.87M | Sell |
44,060
-31,155
| -41% | -$2.03M | 0.31% | 48 |
|
|
2016
Q4 | $4.71M | Buy |
75,215
+24,255
| +48% | +$1.52M | 0.56% | 38 |
|
|
2016
Q3 | $3.21M | Sell |
50,960
-8,595
| -14% | -$542K | 0.4% | 48 |
|
|
2016
Q2 | $3.69M | Buy |
59,555
+4,021
| +7% | +$249K | 0.44% | 46 |
|
|
2016
Q1 | $3.17M | Buy |
55,534
+770
| +1% | +$44K | 0.35% | 52 |
|
|
2015
Q4 | $3.24M | Sell |
54,764
-325
| -0.6% | -$19.3K | 0.32% | 58 |
|
|
2015
Q3 | $3M | Sell |
55,089
-19,240
| -26% | -$1.05M | 0.3% | 59 |
|
|
2015
Q2 | $4.99K | Sell |
74,329
-5,225
| -7% | -$351 | 0.33% | 50 |
|
|
2015
Q1 | $4.66M | Sell |
79,554
-2,069
| -3% | -$121K | 0.38% | 53 |
|
|
2014
Q4 | $5.34M | Sell |
81,623
-33,076
| -29% | -$2.16M | 0.44% | 52 |
|
|
2014
Q3 | $6.63M | Buy |
114,699
+39,125
| +52% | +$2.26M | 0.59% | 47 |
|
|
2014
Q2 | $4.27M | Sell |
75,574
-54,263
| -42% | -$3.06M | 0.47% | 57 |
|
|
2014
Q1 | $6.67M | Buy |
129,837
+22,399
| +21% | +$1.15M | 0.54% | 52 |
|
|
2013
Q4 | $5.67M | Buy |
107,438
+44,163
| +70% | +$2.33M | 0.48% | 48 |
|
|
2013
Q3 | $2.83M | Buy |
63,275
+20,105
| +47% | +$899K | 0.24% | 72 |
|
|
2013
Q2 | $1.79M | Buy |
+43,170
| New | +$1.79M | 0.16% | 88 |
|